Sooyeon Lee

Sooyeon Lee

Auto-generated profile, based on publicly available information

Sooyeon Lee

Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Diabetes
Verified
Journal Article
Open access
PDF file
SLSooyeon Lee
Sooyeon Lee
HXHaixia Xu
Haixia Xu
AVAidan Van Vleck
Aidan Van Vleck
AMAlex M. Mawla
Alex M. Mawla
ALAlbert Mao Li
Albert Mao Li
JAJustin P. Annes
Justin P. Annes
Mitochondrial dysfunction plays a central role in type 2 diabetes (T2D); however, the pathogenic mechanisms in pancreatic β-cells are incompletely elucidated. Succinate dehydrogenase (SDH) is a key mitochondrial enzyme with dual functions in the tricarboxylic acid cycle and electron transport chain. Using samples from human with diabetes and a mouse model of β-cell–specific SDH ablation (SDHBβKO), we define SDH deficiency as a driver of mitochondrial dysfunction in β-cell failure and insulinopenic diabetes. β-Cell SDH deficiency impairs glucose-induced respiratory oxidative phosphorylation and mitochondrial membrane potential collapse, thereby compromising glucose-stimulated ATP production, insulin secretion, and β-cell growth. Mechanistically, metabolomic and transcriptomic studies reveal that the loss of SDH causes excess succinate accumulation, which inappropriately activates mammalian target of rapamycin (mTOR) complex 1–regulated metabolic anabolism, including increased SREBP-regulated lipid synthesis. These alterations, which mirror diabetes-associated human β-cell dysfunction, are partially reversed by acute mTOR inhibition with rapamycin. We propose SDH deficiency as a contributing mechanism to the progressive β-cell failure of diabetes and identify mTOR complex 1 inhibition as a potential mitigation strategy.

1 January 2009 in Applied Entomology and Zoology
Verified
Journal Article
Open access
HKHunsung Kim
Hunsung Kim
SBSunghoon Baek
Sunghoon Baek
SKSe-Jin Kim
Se-Jin Kim
SLSoo-Yeon Lee
Soo-Yeon Lee
JLJoonho Lee
Joonho Lee

1 December 2016 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
SLSooyeon Lee
Sooyeon Lee
SKShannon Kelleher
Shannon Kelleher

9 December 2021 in Endocrinology
Verified
Journal Article
Open access
PDF file
RLRayhan A Lal
Rayhan A Lal
HMHannah P Moeller
Hannah P Moeller
ETElla A Thomson
Ella A Thomson
THTimothy M Horton
Timothy M Horton
SLSooyeon Lee
Sooyeon Lee
JAJustin P Annes
Justin P Annes
Pathogenic INS gene mutations are causative for mutant INS-gene-induced diabetes of youth (MIDY). We characterize a novel de novo heterozygous INS gene mutation (c.289A>C, p.T97P) that presented in an autoantibody-negative 5-month-old male infant with severe diabetic ketoacidosis. In silico pathogenicity prediction tools provided contradictory interpretations, while structural modeling indicated a deleterious effect on proinsulin folding. Transfection of wildtype and INS p.T97P expression and luciferase reporter constructs demonstrated elevated intracellular mutant proinsulin levels and dramatically impaired proinsulin/insulin and luciferase secretion. Notably, proteasome inhibition partially and selectively rescued INS p.T97P-derived luciferase secretion. Additionally, expression of INS p.T97P caused increased intracellular proinsulin aggregate formation and XBP-1s protein levels, consistent with induction of endoplasmic reticulum stress. We conclude that INS p.T97P is a newly identified pathogenic A-chain variant that is causative for MIDY via disruption of proinsulin folding and processing with induction of the endoplasmic reticulum stress response.

1 April 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
RMRonald Mack
Ronald Mack
ZBZeynep Bostanci
Zeynep Bostanci
SASamina Alam
Samina Alam
SLSooyeon Lee
Sooyeon Lee
DSDavid Soybel
David Soybel
SKShannon Kelleher
Shannon Kelleher
Breast cancer is the most common cancer among women. While breastfeeding can reduce breast cancer risk, several studies found no protective effect. We showed that marginal zinc (Zn) intake compromises mammary gland (MG) expansion and function during lactation and is associated with hallmarks of pre‐neoplastic lesions such as collagen deposition, macrophage infiltration, and ductal hyperplasia in the MG of nulliparous mice. Herein, we hypothesized that marginal Zn deficiency abrogates the protective effect of breastfeeding on breast cancer risk. C57BL/6 mice were fed a Zn adequate (ZA; 30mg Zn/kg) or Zn deficient (ZD; 15mg Zn/ kg) diet. Mice were bred, and 2 wk post‐weaning were gavaged with 7,12‐dimethylbenzanthracene (DMBA; 1mg/0.1mL corn oil) or corn oil (control) weekly for 4 wk. Tumor progression was monitored for 24 wk. ZD mice had lower matrix metalloproteinase 2 activity (p<0.01) and insufficient involution, shorter tumor latency (p=0.05), and tended to have greater palpable (35% vs 12% p=0.137) and non‐palpable tumors (p=0.08). ZD mice had greater oxidative stress, e‐cadherin expression and collagen deposition in the MG. Moreover, mammary tumors in ZD mice accumulated Zn and had characteristics of a more invasive phenotype. Our results suggest that consuming inadequate dietary Zn may impair post‐ lactational regression and abrogate the protective effect of breastfeeding on breast cancer. Grant Funding Source : Intramural support, Departments of Surgery and Nutritional Sciences, Penn State University

15 June 2022 in Bone Reports
Verified
Journal Article
Open access
Mubashir AhmadMubashir Ahmad
Mubashir Ahmad
SLSooyeon Lee
Sooyeon Lee
SVSabine Vettorazzi
Sabine Vettorazzi
MSMehmet Sacma
Mehmet Sacma
MSMerle Stein
Merle Stein
JTJan Tuckermann
Jan Tuckermann